* Nutex Health Inc NUTX.OQ NUTX.O is expected to report
results on May 11 (estimated).
* The Fort Lauderdale Florida-based company is expected to
report
revenue of $56.05 million, according to the mean estimate from 2
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Nutex Health Inc is
for a
loss of 1 cent per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts had fallen by
about 50.0%
in the last three months.
* Wall Street's median 12-month price target for Nutex
Health Inc
is $3, above its last closing price of $0.55.
This summary was machine generated May 10 at 01:36 GMT. All
figures in US dollars unless otherwise stated